352 related articles for article (PubMed ID: 12060391)
1. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.
Emmert S; Slor H; Busch DB; Batko S; Albert RB; Coleman D; Khan SG; Abu-Libdeh B; DiGiovanna JJ; Cunningham BB; Lee MM; Crollick J; Inui H; Ueda T; Hedayati M; Grossman L; Shahlavi T; Cleaver JE; Kraemer KH
J Invest Dermatol; 2002 Jun; 118(6):972-82. PubMed ID: 12060391
[TBL] [Abstract][Full Text] [Related]
2. The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity.
Lalle P; Nouspikel T; Constantinou A; Thorel F; Clarkson SG
J Invest Dermatol; 2002 Feb; 118(2):344-51. PubMed ID: 11841555
[TBL] [Abstract][Full Text] [Related]
3. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.
Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH
J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128
[TBL] [Abstract][Full Text] [Related]
4. Characterization of three XPG-defective patients identifies three missense mutations that impair repair and transcription.
Schäfer A; Schubert S; Gratchev A; Seebode C; Apel A; Laspe P; Hofmann L; Ohlenbusch A; Mori T; Kobayashi N; Schürer A; Schön MP; Emmert S
J Invest Dermatol; 2013 Jul; 133(7):1841-9. PubMed ID: 23370536
[TBL] [Abstract][Full Text] [Related]
5. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor.
Gozukara EM; Khan SG; Metin A; Emmert S; Busch DB; Shahlavi T; Coleman DM; Miller M; Chinsomboon N; Stefanini M; Kraemer KH
J Invest Dermatol; 2001 Aug; 117(2):197-204. PubMed ID: 11511294
[TBL] [Abstract][Full Text] [Related]
6. DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells.
Moriwaki S; Stefanini M; Lehmann AR; Hoeijmakers JH; Robbins JH; Rapin I; Botta E; Tanganelli B; Vermeulen W; Broughton BC; Kraemer KH
J Invest Dermatol; 1996 Oct; 107(4):647-53. PubMed ID: 8823375
[TBL] [Abstract][Full Text] [Related]
7. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome.
Ellison AR; Nouspikel T; Jaspers NG; Clarkson SG; Gruenert DC
Exp Cell Res; 1998 Aug; 243(1):22-8. PubMed ID: 9716445
[TBL] [Abstract][Full Text] [Related]
8. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function.
Nouspikel T; Lalle P; Leadon SA; Cooper PK; Clarkson SG
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3116-21. PubMed ID: 9096355
[TBL] [Abstract][Full Text] [Related]
9. Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress.
Soltys DT; Rocha CR; Lerner LK; de Souza TA; Munford V; Cabral F; Nardo T; Stefanini M; Sarasin A; Cabral-Neto JB; Menck CF
Hum Mutat; 2013 Mar; 34(3):481-9. PubMed ID: 23255472
[TBL] [Abstract][Full Text] [Related]
10. Xeroderma pigmentosum group G with severe neurological involvement and features of Cockayne syndrome in infancy.
Zafeiriou DI; Thorel F; Andreou A; Kleijer WJ; Raams A; Garritsen VH; Gombakis N; Jaspers NG; Clarkson SG
Pediatr Res; 2001 Mar; 49(3):407-12. PubMed ID: 11228268
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
[TBL] [Abstract][Full Text] [Related]
12. Mutations that disable the DNA repair gene XPG in a xeroderma pigmentosum group G patient.
Nouspikel T; Clarkson SG
Hum Mol Genet; 1994 Jun; 3(6):963-7. PubMed ID: 7951246
[TBL] [Abstract][Full Text] [Related]
13. Pellagra-like condition is xeroderma pigmentosum/Cockayne syndrome complex and niacin confers clinical benefit.
Hijazi H; Salih MA; Hamad MH; Hassan HH; Salih SB; Mohamed KA; Mukhtar MM; Karrar ZA; Ansari S; Ibrahim N; Alkuraya FS
Clin Genet; 2015; 87(1):56-61. PubMed ID: 24354460
[TBL] [Abstract][Full Text] [Related]
14. Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration.
Totonchy MB; Tamura D; Pantell MS; Zalewski C; Bradford PT; Merchant SN; Nadol J; Khan SG; Schiffmann R; Pierson TM; Wiggs E; Griffith AJ; DiGiovanna JJ; Kraemer KH; Brewer CC
Brain; 2013 Jan; 136(Pt 1):194-208. PubMed ID: 23365097
[TBL] [Abstract][Full Text] [Related]
15. Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome.
Broughton BC; Thompson AF; Harcourt SA; Vermeulen W; Hoeijmakers JH; Botta E; Stefanini M; King MD; Weber CA; Cole J
Am J Hum Genet; 1995 Jan; 56(1):167-74. PubMed ID: 7825573
[TBL] [Abstract][Full Text] [Related]
16. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene.
Broughton BC; Berneburg M; Fawcett H; Taylor EM; Arlett CF; Nardo T; Stefanini M; Menefee E; Price VH; Queille S; Sarasin A; Bohnert E; Krutmann J; Davidson R; Kraemer KH; Lehmann AR
Hum Mol Genet; 2001 Oct; 10(22):2539-47. PubMed ID: 11709541
[TBL] [Abstract][Full Text] [Related]
17. Heritable genetic alterations in a xeroderma pigmentosum group G/Cockayne syndrome pedigree.
Okinaka RT; Perez-Castro AV; Sena A; Laubscher K; Strniste GF; Park MS; Hernandez R; MacInnes MA; Kraemer KH
Mutat Res; 1997 Nov; 385(2):107-14. PubMed ID: 9447232
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum complementation group G patient with a novel homozygous missense mutation and no neurological abnormalities.
Moriwaki S; Takigawa M; Igarashi N; Nagai Y; Amano H; Ishikawa O; Khan SG; Kraemer KH
Exp Dermatol; 2012 Apr; 21(4):304-7. PubMed ID: 22417308
[TBL] [Abstract][Full Text] [Related]
19. A stable XPG protein is required for proper ribosome biogenesis: Insights on the phenotype of combinate Xeroderma Pigmentosum/Cockayne Syndrome patients.
Taupelet F; Donnio LM; Magnani C; Mari PO; Giglia-Mari G
PLoS One; 2022; 17(7):e0271246. PubMed ID: 35802638
[TBL] [Abstract][Full Text] [Related]
20. Xeroderma pigmentosum and molecular cloning of DNA repair genes.
Boulikas T
Anticancer Res; 1996; 16(2):693-708. PubMed ID: 8687116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
